Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Chronic Heart Failure

Free Subscription Articles published in PLoS One Retrieve available abstracts of 253 articles: HTML format

Single Articles

January 2024
1. EDWIN G, Alphonce B, Meremo A, Meda JR, et al
   Prevalence, clinical correlates and outcomes of cardiorenal anemia syndrome among patients with heart failure attending tertiary referral hospital in Dodoma, Tanzania: A protocol of a prospective observational study.
   PLoS One. 2024;19:e0292764.
   PubMed     Abstract available
   
   
   
2. SCHOLTEN M, Davidge J, Agvall B, Halling A, et al
   Comorbidities in heart failure patients that predict cardiovascular readmissions within 100 days-An observational study.
   PLoS One. 2024;19:e0296527.
   PubMed     Abstract available
   
   
   
3. AMMANAMANCHI N, Yester J, Bargaje AP, Thomas D, et al
   Elimination of 15N-thymidine after oral administration in human infants.
   PLoS One. 2024;19:e0295651.
   PubMed     Abstract available
   
   
   
4. SCHIAVO S, Brenna CTA, Albertini L, Djaiani G, et al
   Safety of hyperbaric oxygen therapy in patients with heart failure: A retrospective cohort study.
   PLoS One. 2024;19:e0293484.
   PubMed     Abstract available
   
   
   
5. INOUE N, Morikawa S, Ogane T, Hiramatsu T, et al
   Clinical value of the fibrosis-4 index in predicting mortality in patients with right ventricular pacing.
   PLoS One. 2024;19:e0294221.
   PubMed     Abstract available
   
   
   
6. JIANG L, Liu J, Yang Z, Wang J, et al
   Downregulation of the CD151 protects the cardiac function by the crosstalk between the endothelial cells and cardiomyocytes via exosomes.
   PLoS One. 2024;19:e0297121.
   PubMed     Abstract available
   
   
   
7. PALFFY E, Lewis DJ
   Real-World evidence revelations: The potential of patient support programmes to provide data on medication usage.
   PLoS One. 2024;19:e0295226.
   PubMed     Abstract available
   
   
   
8. MAEDA M, Humber D, Hida E, Ohtani T, et al
   Lower doses of carvedilol in Japanese heart failure patients with reduced ejection fraction could show the potential to be non-inferior to higher doses in US patients: An international collaborative observational study.
   PLoS One. 2024;19:e0299510.
   PubMed     Abstract available
   
   
   
9. CAGGIANELLI G, Alivernini F, Chirico A, Iovino P, et al
   The relationship between caregiver contribution to self-care and patient quality of life in heart failure: A longitudinal mediation analysis.
   PLoS One. 2024;19:e0300101.
   PubMed     Abstract available
   
   
   
10. NASCIMENTO PMC, Rodrigues Junior LF, Felix Mediano MF, Goncalves da Silva V, et al
    Prevalence and impact of sarcopenia in individuals with heart failure with reduced ejection fraction (the SARC-HF study): A prospective observational study protocol.
    PLoS One. 2024;19:e0300918.
    PubMed     Abstract available
    
    
    
11. CHENG T, Yu D, Qiu X, OuYang W, et al
    The relationship between a series of inflammatory markers on the risk of heart failure in different gender groups: Analysis from NHANES 2015-2018.
    PLoS One. 2024;19:e0296936.
    PubMed     Abstract available
    
    
    
12. MAURY P, Sanchis K, Djouadi K, Cariou E, et al
    Catheter ablation of atrial arrhythmias in cardiac amyloidosis: Impact on heart failure and mortality.
    PLoS One. 2024;19:e0301753.
    PubMed     Abstract available
    
    
    
13. WIEST C, Philipp A, Foltan M, Geismann F, et al
    Refractory circulatory failure in COVID-19 patients treated with veno-arterial ECMO a retrospective single-center experience.
    PLoS One. 2024;19:e0298342.
    PubMed     Abstract available
    
    
    
14. EL-MALAHI O, Mohajeri D, Mincu R, Bauerle A, et al
    Beneficial impacts of physical activity on heart rate variability: A systematic review and meta-analysis.
    PLoS One. 2024;19:e0299793.
    PubMed     Abstract available
    
    
    
15. HUTTELMAIER MT, Munsterer S, Morbach C, Sahiti F, et al
    Activated rate-response is associated with increased mortality risk in cardiac device carriers with acute heart failure.
    PLoS One. 2024;19:e0302321.
    PubMed     Abstract available
    
    
    
16. SAIFAN AR, Hayeah HA, Ibrahim AM, Dimitri A, et al
    Experiences on health-related quality of life of Jordanian patients living with heart failure: A qualitative study.
    PLoS One. 2024;19:e0298893.
    PubMed     Abstract available
    
    
    
17. ZHANG X, Ho GWK, Mak YW
    Effectiveness of a videoconferencing group-based dyad acceptance and commitment therapy on the quality of life of chronic heart failure patients and their family caregivers: A study protocol for a randomized controlled trial.
    PLoS One. 2024;19:e0298178.
    PubMed     Abstract available
    
    
    
18. RYE CS, Ofstad AP, Asvold BO, Romundstad PR, et al
    The influence of diagnostic subgroups, patient- and hospital characteristics for the validity of cardiovascular diagnoses-Data from a Norwegian hospital trust.
    PLoS One. 2024;19:e0302181.
    PubMed     Abstract available
    
    
    January 2023
19. 
    Expression of Concern: Corticosteroids Mediate Heart Failure-Induced Depression through Reduced sigma1-Receptor Expression.
    PLoS One. 2023;18:e0279803.
    PubMed    
    
    
    
20. TEE C, Xu H, Fu X, Cui D, et al
    Longitudinal HbA1c trajectory modelling reveals the association of HbA1c and risk of hospitalization for heart failure for patients with type 2 diabetes mellitus.
    PLoS One. 2023;18:e0275610.
    PubMed     Abstract available
    
    
    
21. LEE K, Lee SK, Lee J, Jeon BK, et al
    Protocol of BEYOND trial: Clinical BEnefit of sodium-glucose cotransporter-2 (SGLT-2) inhibitors in rhYthm cONtrol of atrial fibrillation in patients with diabetes mellitus.
    PLoS One. 2023;18:e0280359.
    PubMed     Abstract available
    
    
    
22. EL MAJZOUB I, Kalot N, Khalifeh M, Estelly N, et al
    "Predictors of in-hospital mortality in adult cancer patients with COVID-19 infection presenting to the emergency department: A retrospective study".
    PLoS One. 2023;18:e0278898.
    PubMed     Abstract available
    
    
    
23. CONNOCK M, Auguste P, Obadia JF, Andronis L, et al
    Impact of updated trial data on the cost-effectiveness of percutaneous mitral repair.
    PLoS One. 2023;18:e0280554.
    PubMed     Abstract available
    
    
    
24. ALCOBERRO L, Moliner P, Vime J, Jimenez-Marrero S, et al
    Breaking the 30-day barrier: Long-term effectiveness of a nurse-led 7-step transitional intervention program in heart failure.
    PLoS One. 2023;18:e0279815.
    PubMed     Abstract available
    
    
    
25. SONG Y, Leem J, Dhanani M, McKirnan MD, et al
    Impact of blood factors on endothelial cell metabolism and function in two diverse heart failure models.
    PLoS One. 2023;18:e0281550.
    PubMed     Abstract available
    
    
    
26. LIU T, Xuan H, Wang L, Li X, et al
    The association between serum albumin and long length of stay of patients with acute heart failure: A retrospective study based on the MIMIC-IV database.
    PLoS One. 2023;18:e0282289.
    PubMed     Abstract available
    
    
    
27. LI D, Fu J, Zhao J, Qin J, et al
    A deep learning system for heart failure mortality prediction.
    PLoS One. 2023;18:e0276835.
    PubMed     Abstract available
    
    
    
28. GANDIN I, Saccani S, Coser A, Scagnetto A, et al
    Deep-learning-based prognostic modeling for incident heart failure in patients with diabetes using electronic health records: A retrospective cohort study.
    PLoS One. 2023;18:e0281878.
    PubMed     Abstract available
    
    
    
29. HU T, Yao W, Li Y, Liu Y, et al
    Interaction of acute heart failure and acute kidney injury on in-hospital mortality of critically ill patients with sepsis: A retrospective observational study.
    PLoS One. 2023;18:e0282842.
    PubMed     Abstract available
    
    
    
30. BORCHERS P, Pfisterer D, Scherpf M, Voigt K, et al
    Needs- and user-oriented development of contactless camera-based telemonitoring in heart disease-Results of an acceptance survey from the Home-based Healthcare Project (feasibility project).
    PLoS One. 2023;18:e0282527.
    PubMed     Abstract available
    
    
    
31. ANJULLO BB, Kumaso SK, Erango MA
    Joint modeling of longitudinal change in pulse rate and survival time of heart failure patients treated at Arbaminch General Hospital, Southern Ethiopia.
    PLoS One. 2023;18:e0282637.
    PubMed     Abstract available
    
    
    
32. CALLAHAN K, Acharya Y, Hollenbeak CS
    Validity of ICD codes to identify do-not-resuscitate orders among older adults with heart failure: A single center study.
    PLoS One. 2023;18:e0283045.
    PubMed     Abstract available
    
    
    
33. MULUGETA H, Sinclair PM, Wilson A
    Prevalence of depression and its association with health-related quality of life in people with heart failure in low- and middle-income countries: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0283146.
    PubMed     Abstract available
    
    
    
34. BERGMARK RW, Jin G, Semco RS, Santolini M, et al
    Association of hospital centrality in inter-hospital patient-sharing networks with patient mortality and length of stay.
    PLoS One. 2023;18:e0281871.
    PubMed     Abstract available
    
    
    
35. MOON S, Liu S, Kshatriya BSA, Fu S, et al
    Assessing document section heterogeneity across multiple electronic health record systems for computational phenotyping: A case study of heart-failure phenotyping algorithm.
    PLoS One. 2023;18:e0283800.
    PubMed     Abstract available
    
    
    
36. EDMISTON JB, Cohn EG, Teruya SL, Sabogal N, et al
    Clinical and social determinants of health features of SARS-CoV-2 infection among Black and Caribbean Hispanic patients with heart failure: The SCAN-MP Study.
    PLoS One. 2023;18:e0283730.
    PubMed     Abstract available
    
    
    
37. KLEINMAN N, Kammerer J, LaGuerre K, Thakar CV, et al
    Social determinants of patiromer adherence and abandonment: An observational, retrospective, real-world claims analysis.
    PLoS One. 2023;18:e0281775.
    PubMed     Abstract available
    
    
    
38. HUMES HD, Aaronson KD, Buffington DA, Sabbah HN, et al
    Translation of immunomodulatory therapy to treat chronic heart failure: Preclinical studies to first in human.
    PLoS One. 2023;18:e0273138.
    PubMed     Abstract available
    
    
    
39. WU F, Nagele M, Cleres D, Haider T, et al
    Trends in voice characteristics in patients with heart failure (VENTURE) in Switzerland: Protocol for a longitudinal observational pilot study.
    PLoS One. 2023;18:e0283052.
    PubMed     Abstract available
    
    
    
40. LI Z, Liu M, Chen M, Luo G, et al
    Clinical effect of Danshen decoction in patients with heart failure: A systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2023;18:e0284877.
    PubMed     Abstract available
    
    
    
41. CATALANO S, Moyer J, Weaver A, Di Q, et al
    Associations between long-term fine particulate matter exposure and hospital procedures in heart failure patients.
    PLoS One. 2023;18:e0283759.
    PubMed     Abstract available
    
    
    
42. SIVAKUMAR B, Lemonde M, Stein M, Mak S, et al
    Patient perspectives on the use of mobile apps to support heart failure management: A qualitative descriptive study.
    PLoS One. 2023;18:e0285659.
    PubMed     Abstract available
    
    
    
43. GODA A, Yanagisawa Y, Takeuchi S, Takeuchi K, et al
    Characteristics of cardiopulmonary exercise testing in patients with combined post- and pre-capillary pulmonary hypertension due to left heart disease.
    PLoS One. 2023;18:e0286057.
    PubMed     Abstract available
    
    
    
44. JONES AK, Yan CL, Rivera Rodriquez BP, Kaur S, et al
    Role of wearable devices in cardiac telerehabilitation: A scoping review.
    PLoS One. 2023;18:e0285801.
    PubMed     Abstract available
    
    
    
45. KWAN JM, Arbune A, Henry ML, Hu R, et al
    Quantitative cardiovascular magnetic resonance findings and clinical risk factors predict cardiovascular outcomes in breast cancer patients.
    PLoS One. 2023;18:e0286364.
    PubMed     Abstract available
    
    
    
46. MALMBORG M, Assad Turky Al-Kahwa A, Kober L, Torp-Pedersen C, et al
    Specialized heart failure clinics versus primary care: Extended registry-based follow-up of the NorthStar trial.
    PLoS One. 2023;18:e0286307.
    PubMed     Abstract available
    
    
    
47. WILLIAMS TB, Crump A, Garza MY, Parker N, et al
    Care delivery team composition effect on hospitalization risk in African Americans with congestive heart failure.
    PLoS One. 2023;18:e0286363.
    PubMed     Abstract available
    
    
    
48. SEKO Y, Kato T, Morimoto T, Yaku H, et al
    Weight loss during follow-up in patients with acute heart failure: From the KCHF registry.
    PLoS One. 2023;18:e0287637.
    PubMed     Abstract available
    
    
    
49. AL SAIKHAN L, Park C, Tillin T, Jones S, et al
    Does 3D-speckle tracking echocardiography improve prediction of major cardiovascular events in a multi-ethnic general population? A Southall and Brent Revisited (SABRE) cohort study.
    PLoS One. 2023;18:e0287173.
    PubMed     Abstract available
    
    
    
50. ONG SC, Low JZ
    Financial burden of heart failure in Malaysia: A perspective from the public healthcare system.
    PLoS One. 2023;18:e0288035.
    PubMed     Abstract available
    
    
    
51. MCMAHON J, Brown Wilson C, Hill L, Tierney P, et al
    Optimising quality of life for people living with heart failure in care homes: Protocol for the co-design and feasibility testing of a digital intervention.
    PLoS One. 2023;18:e0288433.
    PubMed     Abstract available
    
    
    
52. INAGAKI N, Seto N, Lee K, Takahashi Y, et al
    The role of critical care nurses in shared decision-making for patients with severe heart failure: A qualitative study.
    PLoS One. 2023;18:e0288978.
    PubMed     Abstract available
    
    
    
53. HUANG AA, Huang SY
    Dendrogram of transparent feature importance machine learning statistics to classify associations for heart failure: A reanalysis of a retrospective cohort study of the Medical Information Mart for Intensive Care III (MIMIC-III) database.
    PLoS One. 2023;18:e0288819.
    PubMed     Abstract available
    
    
    
54. ZHANG X, Zhou K, You L, Zhang J, et al
    Risk prediction models for mortality and readmission in patients with acute heart failure: A protocol for systematic review, critical appraisal, and meta-analysis.
    PLoS One. 2023;18:e0283307.
    PubMed     Abstract available
    
    
    
55. GU S, Du X, Wang D, Yu Y, et al
    Effects of high intensity interval training versus moderate intensity continuous training on exercise capacity and quality of life in patients with heart failure: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0290362.
    PubMed     Abstract available
    
    
    
56. BEKELE F, Tafese L, Demsash AW, Tesfaye H, et al
    Adherence to self-care practices and associated factors among heart failure patients in Ethiopia: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0288824.
    PubMed     Abstract available
    
    
    
57. AL ATEAH G, Kirschfink A, Frick M, Almalla M, et al
    Echocardiographic determination of right ventricular volumes and ejection fraction: Validation of a truncated cone and rhomboid pyramid formula.
    PLoS One. 2023;18:e0290418.
    PubMed     Abstract available
    
    
    
58. BOROWIEC A, Ozdowska P, Rosinska M, Jagiello-Gruszfeld A, et al
    Prognostic value of coronary atherosclerosis and CAC score for the risk of chemotherapy-related cardiac dysfunction (CTRCD): The protocol of ANTEC study.
    PLoS One. 2023;18:e0288146.
    PubMed     Abstract available
    
    
    
59. DATTANI R, Ul-Haq Z, Shah M, Goldet G, et al
    Association and progression of multi-morbidity with Chronic Kidney Disease stage 3a secondary to Type 2 Diabetes Mellitus, grouped by albuminuria status in the multi-ethnic population of Northwest London: A real-world study.
    PLoS One. 2023;18:e0289838.
    PubMed     Abstract available
    
    
    
60. KUBILIUTE I, Vitkauskaite M, Urboniene J, Svetikas L, et al
    Clinical characteristics and predictors for in-hospital mortality in adult COVID-19 patients: A retrospective single center cohort study in Vilnius, Lithuania.
    PLoS One. 2023;18:e0290656.
    PubMed     Abstract available
    
    
    
61. MCHARO TL, Iseselo MK, Kahema SE, Tarimo EAM, et al
    Experiences of family caregivers in caring for patients with heart failure admitted at Jakaya Kikwete Cardiac Institute, Dar es Salaam, Tanzania: A qualitative study.
    PLoS One. 2023;18:e0280698.
    PubMed     Abstract available
    
    
    
62. CHEN CW, Chang CW, Lin YC, Chen WT, et al
    Comparison of clinical outcomes of angiotensin receptor blockers with angiotensin-converting enzyme inhibitors in patients with acute myocardial infarction.
    PLoS One. 2023;18:e0290251.
    PubMed     Abstract available
    
    
    
63. GARNIER A, Leroy J, Delomenie C, Mateo P, et al
    Modulation of cardiac cAMP signaling by AMPK and its adjustments in pressure overload-induced myocardial dysfunction in rat and mouse.
    PLoS One. 2023;18:e0292015.
    PubMed     Abstract available
    
    
    
64. S JARAB A, Al-Qerem WA, Hamam H, Abu Heshmeh S, et al
    Glycemic control and its associated factors among diabetic heart failure outpatients at two major hospitals in Jordan.
    PLoS One. 2023;18:e0285142.
    PubMed     Abstract available
    
    
    
65. SCHOLTEN M, Halling A
    Associations of heart failure to prevalence of haematologic- and solid malignancies in southern Sweden: A cross-sectional study.
    PLoS One. 2023;18:e0292853.
    PubMed     Abstract available
    
    
    
66. FERNANDEZ-MENDOZA G, Mendez-Fernandez A, Alves-Figueiredo HJ, Garcia-Rivas G, et al
    Exploring the mechanisms underlying stroke volume variability reduction in a murine model of heart failure with reduced ejection fraction.
    PLoS One. 2023;18:e0292687.
    PubMed     Abstract available
    
    
    
67. KIM JM, Maqsood MH, Makuvire T, McIlvennan CK, et al
    Gender-based differences in decision making, quality of life and survival among patients undergoing left ventricular assist device evaluation.
    PLoS One. 2023;18:e0293121.
    PubMed     Abstract available
    
    
    
68. WU KY, Wang X, Youngson E, Gouda P, et al
    Sex differences in post-operative outcomes following non-cardiac surgery.
    PLoS One. 2023;18:e0293638.
    PubMed     Abstract available
    
    
    
69. WHITTAKER H, Rothnie KJ, Quint JK
    Exploring the impact of varying definitions of exacerbations of chronic obstructive pulmonary disease in routinely collected electronic medical records.
    PLoS One. 2023;18:e0292876.
    PubMed     Abstract available
    
    
    
70. HUGHES-AUSTIN JM, Katz R, Majka DS, Criqui MH, et al
    Serum reactivity to citrullinated protein/peptide antigens and left ventricular structure and function in the Multi-Ethnic Study of Atherosclerosis (MESA).
    PLoS One. 2023;18:e0291967.
    PubMed     Abstract available
    
    
    
71. CANTERI AL, Gusmon LB, Boguszewski CL, Borba VZC, et al
    Bone quality, mineral density, and fractures in heart failure.
    PLoS One. 2023;18:e0293903.
    PubMed     Abstract available
    
    
    
72. KIYOMOTO K, Matsuo I, Suita K, Ohnuki Y, et al
    Oral angiotensin-converting enzyme inhibitor captopril protects the heart from Porphyromonas gingivalis LPS-induced cardiac dysfunction in mice.
    PLoS One. 2023;18:e0292624.
    PubMed     Abstract available
    
    
    
73. HWANG HJ, Lee TG
    Impact on clinical outcomes of renin-angiotensin system inhibitors against doxorubicin-related toxicity in patients with breast cancer and hypertension: A nationwide cohort study in South Korea.
    PLoS One. 2023;18:e0294649.
    PubMed     Abstract available
    
    
    
74. DURANTE A, Younas A, Cuoco A, Boyne J, et al
    Burden among informal caregivers of individuals with heart failure: A mixed methods study.
    PLoS One. 2023;18:e0292948.
    PubMed     Abstract available
    
    
    
75. BILIKUNDI P, Alphonce B, Nyundo A, Meda JR, et al
    Predictors and outcomes of cardiac dyssynchrony among patients with heart failure attending Benjamin Mkapa Hospital in Dodoma, central Tanzania: A protocol of prospective-longitudinal study.
    PLoS One. 2023;18:e0287813.
    PubMed     Abstract available
    
    
    
76. SURIT P, Wongtanasarasin W, Boonnag C, Wittayachamnankul B, et al
    Association between air quality index and effects on emergency department visits for acute respiratory and cardiovascular diseases.
    PLoS One. 2023;18:e0294107.
    PubMed     Abstract available
    
    
    
77. FUKUTA H, Goto T, Kamiya T
    Effects of beta-blocker withdrawal in patients with heart failure with preserved ejection fraction: A protocol for systematic review and meta-analysis.
    PLoS One. 2023;18:e0294347.
    PubMed     Abstract available
    
    
    
78. REYES-FARIAS CI, Reategui-Diaz M, Romani-Romani F, Prokop L, et al
    The effect of sodium-glucose cotransporter 2 inhibitors in patients with chronic kidney disease with or without type 2 diabetes mellitus on cardiovascular and renal outcomes: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0295059.
    PubMed     Abstract available
    
    
    
79. KIM J, Jiang J, Shen S, Setoguchi S, et al
    Trends in cardiac rehabilitation rates among patients admitted for acute heart failure in Japan, 2009-2020.
    PLoS One. 2023;18:e0294844.
    PubMed     Abstract available
    
    
    
80. ZHANG Y, Aaronson KD, Gryak J, Wittrup E, et al
    Predicting need for heart failure advanced therapies using an interpretable tropical geometry-based fuzzy neural network.
    PLoS One. 2023;18:e0295016.
    PubMed     Abstract available
    
    
    
81. HUANG CH, Yang CT, Chang CC
    Traumatic brain injury and risk of heart failure and coronary heart disease: A nationwide population-based cohort study.
    PLoS One. 2023;18:e0295416.
    PubMed     Abstract available
    
    
    
82. SHI L, Huang L, Yin E, Deng J, et al
    Effect of pueraria on left ventricular remodelling in HFrEF: A systematic review and meta-analysis.
    PLoS One. 2023;18:e0295344.
    PubMed     Abstract available
    
    
    
83. AL YOUNIS SM, Hadjileontiadis LJ, Al Shehhi AM, Stefanini C, et al
    Investigating automated regression models for estimating left ventricular ejection fraction levels in heart failure patients using circadian ECG features.
    PLoS One. 2023;18:e0295653.
    PubMed     Abstract available
    
    
    
84. ZHANG J, Hu Z, Tan Y, Ye J, et al
    Causal relationship from heart failure to kidney function and CKD: A bidirectional two-sample mendelian randomization study.
    PLoS One. 2023;18:e0295532.
    PubMed     Abstract available
    
    
    
85. BEKELE F, Tafese L, Garbessa B, Tadasa S, et al
    Burden and predictors of heart failure treatment outcomes in Ethiopia: A systematic review and meta-analysis protocol.
    PLoS One. 2023;18:e0291686.
    PubMed     Abstract available
    
    
    
86. GIL KE, Mikrut K, Mazur J, Black AL, et al
    Risk stratification in patients with structurally normal hearts: Does fibrosis type matter?
    PLoS One. 2023;18:e0295519.
    PubMed     Abstract available
    
    
    January 2022
87. XU Z, Neuber S, Nazari-Shafti T, Liu Z, et al
    Impact of procedural variability and study design quality on the efficacy of cell-based therapies for heart failure - a meta-analysis.
    PLoS One. 2022;17:e0261462.
    PubMed     Abstract available
    
    
    
88. LI M, Li Y, Meng Q, Li Y, et al
    Correction: Effects of nurse-led transitional care interventions for patients with heart failure on healthcare utilization: A meta-analysis of randomized controlled trials.
    PLoS One. 2022;17:e0262979.
    PubMed     Abstract available
    
    
    
89. SHIBA M, Kato T, Morimoto T, Yaku H, et al
    Changes in BNP levels from discharge to 6-month visit predict subsequent outcomes in patients with acute heart failure.
    PLoS One. 2022;17:e0263165.
    PubMed     Abstract available
    
    
    
90. LIU X, Liu H, Wang L, Zhang L, et al
    Role of sacubitril-valsartan in the prevention of atrial fibrillation occurrence in patients with heart failure: A systematic review and meta-analysis of randomized controlled trials.
    PLoS One. 2022;17:e0263131.
    PubMed     Abstract available
    
    
    
91. TONNESSEN TC, Melleby AO, Hauge-Iversen IM, Espe EKS, et al
    Impact of delayed type hypersensitivity arthritis on development of heart failure by aortic constriction in mice.
    PLoS One. 2022;17:e0262821.
    PubMed     Abstract available
    
    
    
92. SAKUMA M, Toyoda S, Arikawa T, Koyabu Y, et al
    Topiroxostat versus allopurinol in patients with chronic heart failure complicated by hyperuricemia: A prospective, randomized, open-label, blinded-end-point clinical trial.
    PLoS One. 2022;17:e0261445.
    PubMed     Abstract available
    
    
    
93. ZHENG S, Yang J, Tan TC, Belani S, et al
    Dialysis therapy and mortality in older adults with heart failure and advanced chronic kidney disease: A high-dimensional propensity-matched cohort study.
    PLoS One. 2022;17:e0262706.
    PubMed     Abstract available
    
    
    
94. SHIBATA T, Oishi S, Mizuno A, Ohmori T, et al
    Evaluation of the effectiveness of the physician education program on primary palliative care in heart failure.
    PLoS One. 2022;17:e0263523.
    PubMed     Abstract available
    
    
    
95. CHAPMAN-GOETZ J, Packham N, Gabb G, Potts C, et al
    Acceptability and feasibility of the NPS MedicineWise mobile phone application in supporting medication adherence in patients with chronic heart failure: Protocol for a pilot study.
    PLoS One. 2022;17:e0263284.
    PubMed     Abstract available
    
    
    
96. MARSHALL V, Jewett-Tennant J, Shell-Boyd J, Stevenson L, et al
    Healthcare providers experiences with shared medical appointments for heart failure.
    PLoS One. 2022;17:e0263498.
    PubMed     Abstract available
    
    
    
97. LI N, Zhou G, Zheng Y, Lv D, et al
    Effects of SGLT2 inhibitors on cardiovascular outcomes in patients with stage 3/4 CKD: A meta-analysis.
    PLoS One. 2022;17:e0261986.
    PubMed     Abstract available
    
    
    
98. SONG J, Zhang Q, Ye L, Zheng Y, et al
    The comparison of catheter ablation on hard outcomes versus medical treatment for atrial fibrillation patients: A meta-analysis of randomized, controlled trials with trial sequential analysis.
    PLoS One. 2022;17:e0262702.
    PubMed     Abstract available
    
    
    
99. ZHANG Y, Van Laer AO, Baicu CF, Neff LS, et al
    Phenotypic characterization of primary cardiac fibroblasts from patients with HFpEF.
    PLoS One. 2022;17:e0262479.
    PubMed     Abstract available
    
    
    
100. HODREA J, Saeed A, Molnar A, Fintha A, et al
     SGLT2 inhibitor dapagliflozin prevents atherosclerotic and cardiac complications in experimental type 1 diabetes.
     PLoS One. 2022;17:e0263285.
     PubMed     Abstract available
     
     
     
101. ALTAMURA M, D'Andrea G, Angelini E, Tortorelli FMP, et al
     Psychosomatic syndromes are associated with IL-6 pro-inflammatory cytokine in heart failure patients.
     PLoS One. 2022;17:e0265282.
     PubMed     Abstract available
     
     
     
102. KUJAWSKI SA, Whitaker M, Ritchey MD, Reingold AL, et al
     Rates of respiratory syncytial virus (RSV)-associated hospitalization among adults with congestive heart failure-United States, 2015-2017.
     PLoS One. 2022;17:e0264890.
     PubMed     Abstract available
     
     
     
103. WAJANGA BMK, Kim CY, Peck RN, Bartlett J, et al
     Is lack of health insurance a predictor of worsening of heart failure among adult patients attending referral hospitals in Northwestern Tanzania?
     PLoS One. 2022;17:e0264352.
     PubMed     Abstract available
     
     
     
104. DE JONG KA, Berisha F, Naderpoor N, Appelbe A, et al
     Polycystic ovarian syndrome increases prevalence of concentric hypertrophy in normotensive obese women.
     PLoS One. 2022;17:e0263312.
     PubMed     Abstract available
     
     
     
105. LEE HJ, Kim HK, Lee SC, Ommen SR, et al
     Age-related sex differences in the outcomes of patients with hypertrophic cardiomyopathy.
     PLoS One. 2022;17:e0264580.
     PubMed     Abstract available
     
     
     
106. HARRISON NE, Meram S, Li X, White MB, et al
     Hemodynamic profiles by non-invasive monitoring of cardiac index and vascular tone in acute heart failure patients in the emergency department: External validation and clinical outcomes.
     PLoS One. 2022;17:e0265895.
     PubMed     Abstract available
     
     
     
107. SAAD NS, Mashali MA, Elnakish MT, Hare A, et al
     Effect of hypothyroidism on contractile performance of isolated end-stage failing human myocardium.
     PLoS One. 2022;17:e0265731.
     PubMed     Abstract available
     
     
     
108. SHROUT TA, Pan S, Mitchell GF, Vasan RS, et al
     Association of orthostatic blood pressure response with incident heart failure: The Framingham Heart Study.
     PLoS One. 2022;17:e0267057.
     PubMed     Abstract available
     
     
     
109. BANERAS J, Pariggiano I, Rodenas-Alesina E, Oristrell G, et al
     Optimal opportunistic screening of atrial fibrillation using pulse palpation in cardiology outpatient clinics: Who and how.
     PLoS One. 2022;17:e0266955.
     PubMed     Abstract available
     
     
     
110. ANDERSON KM, Murphy D, Groninger H, Kolm P, et al
     Perceived symptoms as the primary indicators for 30-day heart failure readmission.
     PLoS One. 2022;17:e0267820.
     PubMed     Abstract available
     
     
     
111. YAMAMOTO E, Kato T, Yaku H, Morimoto T, et al
     Appetite loss at discharge from acute decompensated heart failure: Observation from KCHF registry.
     PLoS One. 2022;17:e0267327.
     PubMed     Abstract available
     
     
     
112. RIMBAS RC, Visoiu IS, Magda SL, Mihaila-Baldea S, et al
     New insights into the potential utility of the left atrial function analysis in heart failure with preserved ejection fraction diagnosis.
     PLoS One. 2022;17:e0267962.
     PubMed     Abstract available
     
     
     
113. SHARA N, Bjarnadottir MV, Falah N, Chou J, et al
     Voice activated remote monitoring technology for heart failure patients: Study design, feasibility and observations from a pilot randomized control trial.
     PLoS One. 2022;17:e0267794.
     PubMed     Abstract available
     
     
     
114. DOI T, Noto T, Mita T, Nagahara D, et al
     Prognostic value of nutritional parameters in systolic heart failure with renal dysfunction.
     PLoS One. 2022;17:e0266839.
     PubMed     Abstract available
     
     
     
115. MONREAL G, Koenig SC, Slaughter MS, Morello GF, et al
     Feasibility testing of the Inspired Therapeutics NeoMate mechanical circulatory support system for neonates and infants.
     PLoS One. 2022;17:e0266822.
     PubMed     Abstract available
     
     
     
116. GUARDINO CE, Pan S, Vasan RS, Xanthakis V, et al
     Multi-system trajectories and the incidence of heart failure in the Framingham Offspring Study.
     PLoS One. 2022;17:e0268576.
     PubMed     Abstract available
     
     
     
117. HIGA Y, Nabeshima Y, Kitano T, Kataoka M, et al
     Brain natriuretic peptide measurements using standard biochemical equipment: Comparisons with conventional immunoassays.
     PLoS One. 2022;17:e0268895.
     PubMed     Abstract available
     
     
     
118. LERTSUTTIMETTA T, Tumkosit M, Kaveevorayan P, Chantranuwatana P, et al
     The discrepancies between clinical and histopathological diagnoses of cardiomyopathies in patients with stage D heart failure undergoing heart transplantation.
     PLoS One. 2022;17:e0269019.
     PubMed     Abstract available
     
     
     
119. LIND L, Zethelius B, Byberg L
     Self-reported physical activity and different cardiovascular diseases-Results from updated measurements over 40 years.
     PLoS One. 2022;17:e0269402.
     PubMed     Abstract available
     
     
     
120. SANDSTEDT M, Vukusic K, Ulfenborg B, Jonsson M, et al
     Human intracardiac SSEA4+CD34 cells show features of cycling, immature cardiomyocytes and are distinct from Side Population and C-kit+CD45- cells.
     PLoS One. 2022;17:e0269985.
     PubMed     Abstract available
     
     
     
121. NI L, Miao P, Jiang J, Wan F, et al
     Glycyrrhiza uralensis promote the metabolism of toxic components of Aconitum carmichaeli by CYP3A and alleviate the development of chronic heart failure.
     PLoS One. 2022;17:e0270069.
     PubMed     Abstract available
     
     
     
122. TIGABE TEKLE M, Bekalu AF, Tefera YG
     Length of hospital stay and associated factors among heart failure patients admitted to the University Hospital in Northwest Ethiopia.
     PLoS One. 2022;17:e0270809.
     PubMed     Abstract available
     
     
     
123. WU J, Wang W, Huang Y, Wu H, et al
     Deletion of SM22alpha disrupts the structure and function of caveolae and T-tubules in cardiomyocytes, contributing to heart failure.
     PLoS One. 2022;17:e0271578.
     PubMed     Abstract available
     
     
     
124. KIM Y, Canada JM, Kenyon J, Billingsley H, et al
     Physical activity, sedentary behaviors and all-cause mortality in patients with heart failure: Findings from the NHANES 2007-2014.
     PLoS One. 2022;17:e0271238.
     PubMed     Abstract available
     
     
     
125. ZHU L, Marsh JW, Griffith MP, Collins K, et al
     Predictive model for severe COVID-19 using SARS-CoV-2 whole-genome sequencing and electronic health record data, March 2020-May 2021.
     PLoS One. 2022;17:e0271381.
     PubMed     Abstract available
     
     
     
126. HAN JH, McNaughton CD, Stubblefield WB, Pang PS, et al
     Delirium and its association with short-term outcomes in younger and older patients with acute heart failure.
     PLoS One. 2022;17:e0270889.
     PubMed     Abstract available
     
     
     
127. KANG JO, Ha TW, Jung HU, Lim JE, et al
     A cardiac-null mutation of Prdm16 causes hypotension in mice with cardiac hypertrophy via increased nitric oxide synthase 1.
     PLoS One. 2022;17:e0267938.
     PubMed     Abstract available
     
     
     
128. AMIROVA A, Lucas R, Cowie MR, Haddad M, et al
     Perceived barriers and enablers influencing physical activity in heart failure: A qualitative one-to-one interview study.
     PLoS One. 2022;17:e0271743.
     PubMed     Abstract available
     
     
     
129. ALCARAZ A, Pichon-Riviere A, Rojas-Roque C, Gonzalez JM, et al
     Cost-effectiveness of a centrifugal-flow pump for patients with advanced heart failure in Argentina.
     PLoS One. 2022;17:e0271519.
     PubMed     Abstract available
     
     
     
130. GUO YG, Zhang Y, Liu WL
     The causal relationship between allergic diseases and heart failure: Evidence from Mendelian randomization study.
     PLoS One. 2022;17:e0271985.
     PubMed     Abstract available
     
     
     
131. SMITH KB, Potters TO, Zenarosa GL
     Pretransplant survival of patients with end-stage heart failure under competing risks.
     PLoS One. 2022;17:e0273100.
     PubMed     Abstract available
     
     
     
132. TAJEU GS, Colvin CL, Hardy ST, Bress AP, et al
     Prevalence, risk factors, and cardiovascular disease outcomes associated with persistent blood pressure control: The Jackson Heart Study.
     PLoS One. 2022;17:e0270675.
     PubMed     Abstract available
     
     
     
133. VIGORE M, Granata N, Braga SS, Piaggi G, et al
     Cognitive impairment, frailty and rehabilitation outcome in older cardiorespiratory patients. DEC_FRAinRIAB: Study protocol.
     PLoS One. 2022;17:e0272132.
     PubMed     Abstract available
     
     
     
134. PRADELLA M, Anastasopoulos C, Yang S, Moor M, et al
     Associations between fully-automated, 3D-based functional analysis of the left atrium and classification schemes in atrial fibrillation.
     PLoS One. 2022;17:e0272011.
     PubMed     Abstract available
     
     
     
135. MAZUR A, Brat K, Homolka P, Merta Z, et al
     Ventilatory efficiency is superior to peak oxygen uptake for prediction of lung resection cardiovascular complications.
     PLoS One. 2022;17:e0272984.
     PubMed     Abstract available
     
     
     
136. CHEN Z, Li M, Yin C, Fang Y, et al
     Effects of cardiac rehabilitation on elderly patients with Chronic heart failure: A meta-analysis and systematic review.
     PLoS One. 2022;17:e0273251.
     PubMed     Abstract available
     
     
     
137. KOGEL A, Hepp P, Stegmann T, Tunnemann-Tarr A, et al
     Effects of surgical and FFP2 masks on cardiopulmonary exercise capacity in patients with heart failure.
     PLoS One. 2022;17:e0269470.
     PubMed     Abstract available
     
     
     
138. AKAMA J, Shimizu T, Ando T, Anzai F, et al
     Clinical usefulness of the pattern of non-adherence to anti-platelet regimen in stented patients (PARIS) thrombotic risk score to predict long-term all-cause mortality and heart failure hospitalization after percutaneous coronary intervention.
     PLoS One. 2022;17:e0274287.
     PubMed     Abstract available
     
     
     
139. SADAT-EBRAHIMI SR, Rezabakhsh A, Aslanabadi N, Asadi M, et al
     Novel diagnostic potential of miR-1 in patients with acute heart failure.
     PLoS One. 2022;17:e0275019.
     PubMed     Abstract available
     
     
     
140. SLADE AL, O'Hara ME, Quinn D, Marley L, et al
     Living with a left ventricular assist device: Capturing recipients experiences using group concept mapping software.
     PLoS One. 2022;17:e0273108.
     PubMed     Abstract available
     
     
     
141. MA S, Wang DH
     Knockout of Trpa1 accelerates age-related cardiac fibrosis and dysfunction.
     PLoS One. 2022;17:e0274618.
     PubMed     Abstract available
     
     
     
142. LIU S, Li J, Qu Z, Li R, et al
     The effectiveness of eHealth self-management interventions in patients with chronic heart failure: Protocol for a systematic review and meta-analysis.
     PLoS One. 2022;17:e0268446.
     PubMed     Abstract available
     
     
     
143. FUKUTA H, Hagiwara H, Kamiya T
     Hypoxia-inducible factor prolyl hydroxylase inhibitors for anemia in heart failure patients: A protocol for systematic review and meta-analysis.
     PLoS One. 2022;17:e0275311.
     PubMed     Abstract available
     
     
     
144. SEDLACEK K, Polasek R, Jansova H, Grieco D, et al
     Inadvertent QRS prolongation by an optimization device-based algorithm in patients with cardiac resynchronization therapy.
     PLoS One. 2022;17:e0275276.
     PubMed     Abstract available
     
     
     
145. HUANG J, Tang X, Liang X, Wen Q, et al
     Correction: The Effects of 17-Methoxyl-7-Hydroxy-Benzene-Furanchalcone on the Pressure Overload-Induced Progression of Cardiac Hypertrophy to Cardiac Failure.
     PLoS One. 2022;17:e0276104.
     PubMed     Abstract available
     
     
     
146. HUSSEN NM, Workie DL, Biresaw HB
     Survival time to complications of congestive heart failure patients at Felege Hiwot comprehensive specialized referral hospital, Bahir Dar, Ethiopia.
     PLoS One. 2022;17:e0276440.
     PubMed     Abstract available
     
     
     
147. LIM J, Hwang IC, Choi HM, Yoon YE, et al
     Comparison of cardiovascular and renal outcomes between dapagliflozin and empagliflozin in patients with type 2 diabetes without prior cardiovascular or renal disease.
     PLoS One. 2022;17:e0269414.
     PubMed     Abstract available
     
     
     
148. ROTH S, Fox H, M'Pembele R, Morshuis M, et al
     Noninvasive evaluation of the hemodynamic status in patients after heart transplantation or left ventricular assist device implantation.
     PLoS One. 2022;17:e0275977.
     PubMed     Abstract available
     
     
     
149. BAIG M, Moafi-Madani M, Qureshi R, Roberts MB, et al
     Heart rate variability and the risk of heart failure and its subtypes in post-menopausal women: The Women's Health Initiative study.
     PLoS One. 2022;17:e0276585.
     PubMed     Abstract available
     
     
     
150. WATSON DE, Marashi-Pour S, Tran B, Witchard A, et al
     Patient-reported experiences and outcomes following hospital care are associated with risk of readmission among adults with chronic health conditions.
     PLoS One. 2022;17:e0276812.
     PubMed     Abstract available
     
     
     
151. TAKEDA T, Tsubaki A, Ikeda Y, Kato R, et al
     The impacts of preoperative frailty on readmission after cardiac implantable electrical device implantation.
     PLoS One. 2022;17:e0277115.
     PubMed     Abstract available
     
     
     
152. PICKERING JW, Scrase R, Troughton R, Jamieson HA, et al
     Evaluation of the added value of Brain Natriuretic Peptide to a validated mortality risk-prediction model in older people using a standardised international clinical assessment tool.
     PLoS One. 2022;17:e0277850.
     PubMed     Abstract available
     
     
     
153. LU Z, Teng Y, Wang L, Jiang Y, et al
     Abnormalities of hippocampus and frontal lobes in heart failure patients and animal models with cognitive impairment or depression: A systematic review.
     PLoS One. 2022;17:e0278398.
     PubMed     Abstract available
     
     
     
154. CHOUAIRI F, Mullan CW, Ahmed A, Bhinder J, et al
     Clinical implications of Type 2 diabetes on outcomes after cardiac transplantation.
     PLoS One. 2022;17:e0273111.
     PubMed     Abstract available
     
     
     
155. KING BL, Meyer ML, Chari SV, Hurka-Richardson K, et al
     Accuracy of the electronic health record's problem list in describing multimorbidity in patients with heart failure in the emergency department.
     PLoS One. 2022;17:e0279033.
     PubMed     Abstract available
     
     
     
156. NEMOTO H, Umemura M, Suzuki F, Nagasako A, et al
     Store-operated calcium entry via ORAI1 regulates doxorubicin-induced apoptosis and prevents cardiotoxicity in cardiac fibroblasts.
     PLoS One. 2022;17:e0278613.
     PubMed     Abstract available
     
     
     
157. PFEFFER TJ, Neuser J, Mueller-Leisse J, Hohmann S, et al
     Acute echocardiographic and electrocardiographic effects of triggered left ventricular pacing.
     PLoS One. 2022;17:e0278531.
     PubMed     Abstract available
     
     
     
158. KAWAJI T, Shizuta S, Tanaka M, Nishiwaki S, et al
     Prognostic impact of catheter ablation in patients with asymptomatic atrial fibrillation.
     PLoS One. 2022;17:e0279178.
     PubMed     Abstract available
     
     
     
159. SOLNICK RE, Vijayasiri G, Li Y, Kocher KE, et al
     Emergency department returns and early follow-up visits after heart failure hospitalization: Cohort study examining the role of race.
     PLoS One. 2022;17:e0279394.
     PubMed     Abstract available
     
     
     
160. NDONGALA NJ, Maepa C, Nyondo E, Amstutz A, et al
     Etiology, characteristics and occurrence of heart diseases in rural Lesotho (ECHO-Lesotho): A retrospective echocardiography cohort study.
     PLoS One. 2022;17:e0278406.
     PubMed     Abstract available
     
     
     
161. CHO DH, Lee CJ, Son JW, Choi J, et al
     Temporal trends in heart failure over 11 years in the aging Korean population: A retrospective study using the national health insurance database.
     PLoS One. 2022;17:e0279541.
     PubMed     Abstract available
     
     
     
162. YEH TH, Tu KC, Hung KC, Chuang MH, et al
     Impact of type of dialyzable beta-blockers on subsequent risk of mortality in patients receiving dialysis: A systematic review and meta-analysis.
     PLoS One. 2022;17:e0279680.
     PubMed     Abstract available
     
     
     
163. CHEN EW, Ahmad K, Erqou S, Wu WC, et al
     Particulate matter 2.5, metropolitan status, and heart failure outcomes in US counties: A nationwide ecologic analysis.
     PLoS One. 2022;17:e0279777.
     PubMed     Abstract available
     
     
     
164. TORIBIO M, Awadalla M, Drobni ZD, Quinaglia T, et al
     Cardiac strain is lower among women with HIV in relation to monocyte activation.
     PLoS One. 2022;17:e0279913.
     PubMed     Abstract available
     
     
     January 2021
165. ISHAK WW, Korouri S, Darwish T, Vanle B, et al
     Personalized treatments for depressive symptoms in patients with advanced heart failure: A pragmatic randomized controlled trial.
     PLoS One. 2021;16:e0244453.
     PubMed     Abstract available
     
     
     
166. LU XH, Liu A, Fuh SC, Lian Y, et al
     Recurrent disease progression networks for modelling risk trajectory of heart failure.
     PLoS One. 2021;16:e0245177.
     PubMed     Abstract available
     
     
     
167. YAMAZAKI R, Nishiyama O, Yoshikawa K, Saeki S, et al
     HFpEF without elevated right ventricular systolic pressure is a favorable prognostic indicator in patients with IPF requiring hospitalization for heart failure.
     PLoS One. 2021;16:e0245778.
     PubMed     Abstract available
     
     
     
168. ALHABIB KF, Gamra H, Almahmeed W, Hammoudeh A, et al
     Correction: Acute Myocardial Infarction and Acute Heart Failure in the Middle East and North Africa: Study Design and Pilot Phase Study Results from the PEACE MENA Registry.
     PLoS One. 2021;16:e0246036.
     PubMed     Abstract available
     
     
     
169. KAMATH DY, Bhuvana KB, Salazar LJ, Varghese K, et al
     A qualitative, grounded theory exploration of the determinants of self-care behavior among Indian patients with a lived experience of chronic heart failure.
     PLoS One. 2021;16:e0245659.
     PubMed     Abstract available
     
     
     
170. OGUNTADE AS, Ajayi IO
     Risk factors of heart failure among patients with hypertension attending a tertiary hospital in Ibadan, Nigeria: The RISK-HHF case-control study.
     PLoS One. 2021;16:e0245734.
     PubMed     Abstract available
     
     
     
171. DE MARIA B, Dalla Vecchia LA, Maestri R, Pinna GD, et al
     Lack of association between heart period variability asymmetry and respiratory sinus arrhythmia in healthy and chronic heart failure individuals.
     PLoS One. 2021;16:e0247145.
     PubMed     Abstract available
     
     
     
172. FUNAMIZU T, Nagatomo Y, Saji M, Iguchi N, et al
     Low muscle mass assessed by psoas muscle area is associated with clinical adverse events in elderly patients with heart failure.
     PLoS One. 2021;16:e0247140.
     PubMed     Abstract available
     
     
     
173. YOLA IM, Oh A, Mitchell GF, O'Connor G, et al
     Association of lung diffusion capacity with cardiac remodeling and risk of heart failure: The Framingham heart study.
     PLoS One. 2021;16:e0246355.
     PubMed     Abstract available
     
     
     
174. PIERCE JB, Shah NS, Petito LC, Pool L, et al
     Trends in heart failure-related cardiovascular mortality in rural versus urban United States counties, 2011-2018: A cross-sectional study.
     PLoS One. 2021;16:e0246813.
     PubMed     Abstract available
     
     
     
175. IBE T, Wada H, Sakakura K, Ugata Y, et al
     Combined pre- and post-capillary pulmonary hypertension: The clinical implications for patients with heart failure.
     PLoS One. 2021;16:e0247987.
     PubMed     Abstract available
     
     
     
176. MCHORNEY CA, Mansukhani SG, Anatchkova M, Taylor N, et al
     The impact of heart failure on patients and caregivers: A qualitative study.
     PLoS One. 2021;16:e0248240.
     PubMed     Abstract available
     
     
     
177. PUWANANT S, Sinphurmsukskul S, Krailak L, Nakaviroj P, et al
     The impact of the coronavirus disease and Tele-Heart Failure Clinic on cardiovascular mortality and heart failure hospitalization in ambulatory patients with heart failure.
     PLoS One. 2021;16:e0249043.
     PubMed     Abstract available
     
     
     
178. KAWADA K, Fukuda H, Kubo T, Ohta T, et al
     Added value of anxiolytic benzodiazepines in predictive models on severe delirium in patients with acute decompensated heart failure: A retrospective analysis.
     PLoS One. 2021;16:e0250372.
     PubMed     Abstract available
     
     
     
179. BAMFORTH RJ, Chhibba R, Ferguson TW, Sabourin J, et al
     Strategies to prevent hospital readmission and death in patients with chronic heart failure, chronic obstructive pulmonary disease, and chronic kidney disease: A systematic review and meta-analysis.
     PLoS One. 2021;16:e0249542.
     PubMed     Abstract available
     
     
     
180. ABE D, Inomata T
     Actual state of "triple therapy" for heart failure patients in eight regions of Japan: An analysis of a nationwide medical claims database.
     PLoS One. 2021;16:e0249711.
     PubMed     Abstract available
     
     
     
181. MBOTWA JL, Kamps M, Baxter PD, Ellison GTH, et al
     Latent class regression improves the predictive acuity and clinical utility of survival prognostication amongst chronic heart failure patients.
     PLoS One. 2021;16:e0243674.
     PubMed     Abstract available
     
     
     
182. LUPON J, Santiago-Vacas E, Cediel G, Codina P, et al
     Circulating neprilysin hypothesis: A new opportunity for sacubitril/valsartan in patients with heart failure and preserved ejection fraction?
     PLoS One. 2021;16:e0249674.
     PubMed     Abstract available
     
     
     
183. KANDA M, Tateishi K, Nakagomi A, Iwahana T, et al
     Association between early intensive care or coronary care unit admission and post-discharge performance of activities of daily living in patients with acute decompensated heart failure.
     PLoS One. 2021;16:e0251505.
     PubMed     Abstract available
     
     
     
184. PONGIGLIONE B, Torbica A, Gale CP, Tavazzi L, et al
     Patient, hospital and country-level risk factors of all-cause mortality among patients with chronic heart failure: Prospective international cohort study.
     PLoS One. 2021;16:e0250931.
     PubMed     Abstract available
     
     
     
185. ALGUREN B, Jernberg T, Vasko P, Selb M, et al
     Content comparison and person-centeredness of standards for quality improvement in cardiovascular health care.
     PLoS One. 2021;16:e0244874.
     PubMed     Abstract available
     
     
     
186. ABID L, Charfeddine S, Kammoun I, Ben Halima M, et al
     Epidemiology of heart failure and long-term follow-up outcomes in a north-African population: Results from the NAtional TUnisian REgistry of Heart Failure (NATURE-HF).
     PLoS One. 2021;16:e0251658.
     PubMed     Abstract available
     
     
     
187. CHOU YY, Ward JL, Barron LZ, Murphy SD, et al
     Focused ultrasound of the caudal vena cava in dogs with cavitary effusions or congestive heart failure: A prospective, observational study.
     PLoS One. 2021;16:e0252544.
     PubMed     Abstract available
     
     
     
188. TAKAHASHI S, Tanno K, Yonekura Y, Ohsawa M, et al
     Low educational level increases functional disability risk subsequent to heart failure in Japan: On behalf of the Iwate KENCO study group.
     PLoS One. 2021;16:e0253017.
     PubMed     Abstract available
     
     
     
189. MAHESRI M, Chin K, Kumar A, Barve A, et al
     External validation of a claims-based model to predict left ventricular ejection fraction class in patients with heart failure.
     PLoS One. 2021;16:e0252903.
     PubMed     Abstract available
     
     
     
190. IBE T, Wada H, Sakakura K, Ugata Y, et al
     Cardiac index predicts long-term outcomes in patients with heart failure.
     PLoS One. 2021;16:e0252833.
     PubMed     Abstract available
     
     
     
191. KATO M, Mori Y, Watanabe D, Onoda H, et al
     Relationship between average daily rehabilitation time and decline in instrumental activity of daily living among older patients with heart failure: A preliminary analysis of a multicenter cohort study, SURUGA-CARE.
     PLoS One. 2021;16:e0254128.
     PubMed     Abstract available
     
     
     
192. KAWASE Y, Kato T, Morimoto T, Hata R, et al
     Admission systolic blood pressure as a prognostic predictor of acute decompensated heart failure: A report from the KCHF registry.
     PLoS One. 2021;16:e0253999.
     PubMed     Abstract available
     
     
     
193. TANIGUCHI C, Seto N, Shimizu Y
     Outpatient nursing support for self-monitoring in patients with chronic heart failure.
     PLoS One. 2021;16:e0254019.
     PubMed     Abstract available
     
     
     
194. HAMO CE, Abdelmoneim SS, Han SY, Chandy E, et al
     OUTpatient intravenous LASix Trial in reducing hospitalization for acute decompensated heart failure (OUTLAST).
     PLoS One. 2021;16:e0253014.
     PubMed     Abstract available
     
     
     
195. GOLAND S, Volodarsky I, Fabricant Y, Livschitz S, et al
     Wild-type TTR amyloidosis among patients with unexplained heart failure and systolic LV dysfunction.
     PLoS One. 2021;16:e0254104.
     PubMed     Abstract available
     
     
     
196. CHO JH, Leong D, Cuk N, Ebinger JE, et al
     Delayed repolarization and ventricular tachycardia in patients with heart failure and preserved ejection fraction.
     PLoS One. 2021;16:e0254641.
     PubMed     Abstract available
     
     
     
197. PRATTIPATI S, Sakita FM, Kweka GL, Tarimo TG, et al
     Heart failure care and outcomes in a Tanzanian emergency department: A prospective observational study.
     PLoS One. 2021;16:e0254609.
     PubMed     Abstract available
     
     
     
198. LOKAJ P, Spinar J, Spinarova L, Malek F, et al
     Prognostic value of high-sensitivity cardiac troponin I in heart failure patients with mid-range and reduced ejection fraction.
     PLoS One. 2021;16:e0255271.
     PubMed     Abstract available
     
     
     
199. CHOI YJ, Park JY, Lee HS, Suh J, et al
     Variable effects of underlying diseases on the prognosis of patients with COVID-19.
     PLoS One. 2021;16:e0254258.
     PubMed     Abstract available
     
     
     
200. LI CX, Liang S, Gao L, Liu H, et al
     Cardiovascular outcomes associated with SGLT-2 inhibitors versus other glucose-lowering drugs in patients with type 2 diabetes: A real-world systematic review and meta-analysis.
     PLoS One. 2021;16:e0244689.
     PubMed     Abstract available
     
     
     
201. RORTH R, Clausen MF, Fosbol EL, Mogensen UM, et al
     Initiation of domiciliary care and nursing home admission following first hospitalization for heart failure, stroke, chronic obstructive pulmonary disease or cancer.
     PLoS One. 2021;16:e0255364.
     PubMed     Abstract available
     
     
     
202. AREVALOS V, Ortega-Paz L, Fernandez-Rodriguez D, Alfonso Jimenez-Diaz V, et al
     Long-term effects of coronavirus disease 2019 on the cardiovascular system, CV COVID registry: A structured summary of a study protocol.
     PLoS One. 2021;16:e0255263.
     PubMed     Abstract available
     
     
     
203. ACHARYA R, Patel A, Schultz E, Bourgeois M, et al
     Fluid resuscitation and outcomes in heart failure patients with severe sepsis or septic shock: A retrospective case-control study.
     PLoS One. 2021;16:e0256368.
     PubMed     Abstract available
     
     
     
204. BECK-FRIIS J, Leach S, Omerovic E, Zeijlon R, et al
     No difference in biomarkers of ischemic heart injury and heart failure in patients with COVID-19 who received treatment with chloroquine phosphate and those who did not.
     PLoS One. 2021;16:e0256035.
     PubMed     Abstract available
     
     
     
205. TURRI-SILVA N, Vale-Lira A, Verboven K, Quaglioti Durigan JL, et al
     High-intensity interval training versus progressive high-intensity circuit resistance training on endothelial function and cardiorespiratory fitness in heart failure: A preliminary randomized controlled trial.
     PLoS One. 2021;16:e0257607.
     PubMed     Abstract available
     
     
     
206. CHOUAIRI F, Mullan CW, Ravindra N, Clark KAA, et al
     Brief report: Cannabis and opioid use disorder among heart failure admissions, 2008-2018.
     PLoS One. 2021;16:e0255514.
     PubMed     Abstract available
     
     
     
207. RUFF C, Gerharz A, Groll A, Stoll F, et al
     Disease-dependent variations in the timing and causes of readmissions in Germany: A claims data analysis for six different conditions.
     PLoS One. 2021;16:e0250298.
     PubMed     Abstract available
     
     
     
208. PERRY A, Loh F, Adamo L, Zhang KW, et al
     Unsupervised cluster analysis of patients with recovered left ventricular ejection fraction identifies unique clinical phenotypes.
     PLoS One. 2021;16:e0248317.
     PubMed     Abstract available
     
     
     
209. CHUANG AM, Nguyen MT, Khan E, Jones D, et al
     Troponin elevation pattern and subsequent cardiac and non-cardiac outcomes: Implementing the Fourth Universal Definition of Myocardial Infarction and high-sensitivity troponin at a population level.
     PLoS One. 2021;16:e0248289.
     PubMed     Abstract available
     
     
     
210. LV S, Ru S
     The prevalence of malnutrition and its effects on the all-cause mortality among patients with heart failure: A systematic review and meta-analysis.
     PLoS One. 2021;16:e0259300.
     PubMed     Abstract available
     
     
     
211. JONSSON HOLMDAHL A, Norberg H, Valham F, Bergdahl E, et al
     Mineralocorticoid receptor antagonists use in patients with heart failure and impaired renal function.
     PLoS One. 2021;16:e0258949.
     PubMed     Abstract available
     
     
     
212. IWAHANA T, Saito Y, Okada S, Kato H, et al
     Safety and efficacy of esaxerenone in Japanese hypertensive patients with heart failure with reduced ejection fraction: A retrospective study.
     PLoS One. 2021;16:e0259485.
     PubMed     Abstract available
     
     
     
213. GALLARD A, Galli E, Hubert A, Bidaut A, et al
     Echocardiographic view and feature selection for the estimation of the response to CRT.
     PLoS One. 2021;16:e0252857.
     PubMed     Abstract available
     
     
     
214. ITZHAKI BEN ZADOK O, Vaturi M, Vaxman I, Iakobishvili Z, et al
     Differences in the characteristics and contemporary cardiac outcomes of patients with light-chain versus transthyretin cardiac amyloidosis.
     PLoS One. 2021;16:e0255487.
     PubMed     Abstract available
     
     
     
215. KITAGAWA Y, Kawamura I, Suzuki K, Okada H, et al
     Serum syndecan-1 concentration in hospitalized patients with heart failure may predict readmission-free survival.
     PLoS One. 2021;16:e0260350.
     PubMed     Abstract available
     
     
     
216. LI M, Li Y, Meng Q, Li Y, et al
     Effects of nurse-led transitional care interventions for patients with heart failure on healthcare utilization: A meta-analysis of randomized controlled trials.
     PLoS One. 2021;16:e0261300.
     PubMed     Abstract available
     
     
     
217. DUONG SQ, Zheng L, Xia M, Jin B, et al
     Identification of patients at risk of new onset heart failure: Utilizing a large statewide health information exchange to train and validate a risk prediction model.
     PLoS One. 2021;16:e0260885.
     PubMed     Abstract available
     
     
     
218. SUN Y, Pavey H, Wilkinson I, Fisk M, et al
     Role of the IL-33/ST2 axis in cardiovascular disease: A systematic review and meta-analysis.
     PLoS One. 2021;16:e0259026.
     PubMed     Abstract available
     
     
     
219. KIM IS, Choi YJ, Choi EY, Min PK, et al
     Comparison of risk profiles for new-onset atrial fibrillation between patients aged <60 and >/=60 years.
     PLoS One. 2021;16:e0258770.
     PubMed     Abstract available
     
     
     
220. MONGILLO J, Vescovo G, Bramanti B
     Belly fat or bloating? New insights into the physical appearance of St Anthony of Padua.
     PLoS One. 2021;16:e0260505.
     PubMed     Abstract available
     
     
     
221. SCAGLIONE A, Panzarino C, Modica M, Tavanelli M, et al
     Short- and long-term effects of a cardiac rehabilitation program in patients implanted with a left ventricular assist device.
     PLoS One. 2021;16:e0259927.
     PubMed     Abstract available
     
     
     
222. JOKI Y, Konishi H, Ebinuma H, Takasu K, et al
     Circulating sLR11 levels predict severity of pulmonary hypertension due to left heart disease.
     PLoS One. 2021;16:e0261753.
     PubMed     Abstract available
     
     
     
223. SU MI, Liu CW
     Neutrophil-to-lymphocyte ratio associated with an increased risk of mortality in patients with critical limb ischemia.
     PLoS One. 2021;16:e0252030.
     PubMed     Abstract available
     
     
     
224. WANG B, Chen J
     Establishment and validation of a predictive model for mortality within 30 days in patients with sepsis-induced blood pressure drop: A retrospective analysis.
     PLoS One. 2021;16:e0252009.
     PubMed     Abstract available
     
     
     January 2020
225. BLAZQUEZ-BERMEJO Z, Farre N, Llagostera M, Caravaca Perez P, et al
     The development of chronic diuretic resistance can be predicted during a heart-failure hospitalization. Results from the REDIHF registry.
     PLoS One. 2020;15:e0240098.
     PubMed     Abstract available
     
     
     
226. CARABALLO C, McCullough M, Fuery MA, Chouairi F, et al
     COVID-19 infections and outcomes in a live registry of heart failure patients across an integrated health care system.
     PLoS One. 2020;15:e0238829.
     PubMed     Abstract available
     
     
     
227. LI AH, Palmer KS, Taljaard M, Paterson JM, et al
     Effects of quality-based procedure hospital funding reform in Ontario, Canada: An interrupted time series study.
     PLoS One. 2020;15:e0236480.
     PubMed     Abstract available
     
     
     
228. STOLINA M, Luo X, Dwyer D, Han CY, et al
     The evolving systemic biomarker milieu in obese ZSF1 rat model of human cardiometabolic syndrome: Characterization of the model and cardioprotective effect of GDF15.
     PLoS One. 2020;15:e0231234.
     PubMed     Abstract available
     
     
     
229. OKANO T, Motoki H, Minamisawa M, Kimura K, et al
     Cardio-renal and cardio-hepatic interactions predict cardiovascular events in elderly patients with heart failure.
     PLoS One. 2020;15:e0241003.
     PubMed     Abstract available
     
     
     
230. LANGSETH MS, Andersen GO, Husebye T, Arnesen H, et al
     Neutrophil extracellular trap components and myocardial recovery in post-ischemic acute heart failure.
     PLoS One. 2020;15:e0241333.
     PubMed     Abstract available
     
     
     
231. IACCARINO G, Grassi G, Borghi C, Carugo S, et al
     Gender differences in predictors of intensive care units admission among COVID-19 patients: The results of the SARS-RAS study of the Italian Society of Hypertension.
     PLoS One. 2020;15:e0237297.
     PubMed     Abstract available
     
     
     
232. VALENTE C, Guglielmini C, Domenech O, Contiero B, et al
     Symmetric dimethylarginine in dogs with myxomatous mitral valve disease at various stages of disease severity.
     PLoS One. 2020;15:e0238440.
     PubMed     Abstract available
     
     
     
233. BAVISHI A, Lloyd-Jones DM, Ning H, Vu THT, et al
     Systematic examination of a heart failure risk prediction tool: The pooled cohort equations to prevent heart failure.
     PLoS One. 2020;15:e0240567.
     PubMed     Abstract available
     
     
     
234. LIU N, Hang T, Gao X, Yang W, et al
     The association between soluble suppression of tumorigenicity-2 and long-term prognosis in patients with coronary artery disease: A meta-analysis.
     PLoS One. 2020;15:e0238775.
     PubMed     Abstract available
     
     
     
235. ARMOIRY X, Obadia JF, Auguste P, Connock M, et al
     Conflicting findings between the Mitra-Fr and the Coapt trials: Implications regarding the cost-effectiveness of percutaneous repair for heart failure patients with severe secondary mitral regurgitation.
     PLoS One. 2020;15:e0241361.
     PubMed     Abstract available
     
     
     
236. SOHN A, Speier W, Lan E, Aoki K, et al
     Integrating remote monitoring into heart failure patients' care regimen: A pilot study.
     PLoS One. 2020;15:e0242210.
     PubMed     Abstract available
     
     
     
237. MORBACH C, Sahiti F, Tiffe T, Cejka V, et al
     Myocardial work - correlation patterns and reference values from the population-based STAAB cohort study.
     PLoS One. 2020;15:e0239684.
     PubMed     Abstract available
     
     
     
238. MEZZACAPPA C, Ravindra NG, Caraballo C, Chouairi F, et al
     Clinical implications of differences between real world and clinical trial usage of left ventricular assist devices for end stage heart failure.
     PLoS One. 2020;15:e0242928.
     PubMed     Abstract available
     
     
     
239. CHECA C, Medina-Perucha L, Munoz MA, Verdu-Rotellar JM, et al
     Living with advanced heart failure: A qualitative study.
     PLoS One. 2020;15:e0243974.
     PubMed     Abstract available
     
     
     
240. TING SW, Fan PC, Lin YS, Lin MS, et al
     Uremic pruritus and long-term morbidities in the dialysis population.
     PLoS One. 2020;15:e0241088.
     PubMed     Abstract available
     
     
     
241. HAMMOND MM, Shen C, Li S, Kazi DS, et al
     Retrospective evaluation of echocardiographic variables for prediction of heart failure hospitalization in heart failure with preserved versus reduced ejection fraction: A single center experience.
     PLoS One. 2020;15:e0244379.
     PubMed     Abstract available
     
     
     
242. KRUIK-KOLLOFFEL WJ, van der Palen J, Doggen CJM, van Maaren MC, et al
     Heart failure medication after a first hospital admission and risk of heart failure readmission, focus on beta-blockers and renin-angiotensin-aldosterone system medication: A retrospective cohort study in linked databases.
     PLoS One. 2020;15:e0244231.
     PubMed     Abstract available
     
     
     
243. VERHESTRAETEN C, Weijers G, Debleu D, Ciarka A, et al
     Diagnosis, treatment, and follow-up of heart failure patients by general practitioners: A Delphi consensus statement.
     PLoS One. 2020;15:e0244485.
     PubMed     Abstract available
     
     
     
244. SATO Y, Yoshihisa A, Watanabe K, Hotsuki Y, et al
     Association between platelet distribution width and prognosis in patients with heart failure.
     PLoS One. 2020;15:e0244608.
     PubMed     Abstract available
     
     
     
245. KATO T, Yaku H, Morimoto T, Inuzuka Y, et al
     Association of an increase in serum albumin levels with positive 1-year outcomes in acute decompensated heart failure: A cohort study.
     PLoS One. 2020;15:e0243818.
     PubMed     Abstract available
     
     
     
246. DASSANAYAKA S, Brittian KR, Long BW, Higgins LA, et al
     Cardiomyocyte Oga haploinsufficiency increases O-GlcNAcylation but hastens ventricular dysfunction following myocardial infarction.
     PLoS One. 2020;15:e0242250.
     PubMed     Abstract available
     
     
     
247. HER AY, Choi BG, Rha SW, Kim YH, et al
     The impact of angiotensin-converting-enzyme inhibitors versus angiotensin receptor blockers on 3-year clinical outcomes in patients with acute myocardial infarction without hypertension.
     PLoS One. 2020;15:e0242314.
     PubMed     Abstract available
     
     
     
248. DE NATTES T, Litzler PY, Gay A, Nafeh-Bizet C, et al
     Hemolysis induced by Left Ventricular Assist Device is associated with proximal tubulopathy.
     PLoS One. 2020;15:e0242931.
     PubMed     Abstract available
     
     
     
249. SALONEN J, Vahanikkila H, Purokivi M, Kaarteenaho R, et al
     Causes of acute respiratory hospitalizations predict survival in fibrosing interstitial lung diseases.
     PLoS One. 2020;15:e0242860.
     PubMed     Abstract available
     
     
     
250. ROH SY, Choi JI, Kim MS, Cho EY, et al
     Incidence and etiology of sudden cardiac arrest in Koreans: A cohort from the national health insurance service database.
     PLoS One. 2020;15:e0242799.
     PubMed     Abstract available
     
     
     
251. JONES E, Wei J, Nelson MD, Bakir M, et al
     N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) study.
     PLoS One. 2020;15:e0243213.
     PubMed     Abstract available
     
     
     
252. BARENFELD E, Ali L, Wallstrom S, Fors A, et al
     Becoming more of an insider: A grounded theory study on patients' experience of a person-centred e-health intervention.
     PLoS One. 2020;15:e0241801.
     PubMed     Abstract available
     
     
     
253. KAZMI SZH, Habib N, Riaz R, Rizvi SS, et al
     Multiscale based nonlinear dynamics analysis of heart rate variability signals.
     PLoS One. 2020;15:e0243441.
     PubMed     Abstract available
     
     

Thank you for your interest in scientific medicine.

AMEDEO Chronic Heart Failure is free of charge.